Early Development - Biomarker Analysis
Biomarkers are distinctive biological characteristics which can be discovered and measured in parts of the body like the blood, serum or tissue.
They may be a sign of normal or diseased processes in the body. Biomarkers can be specific cells, molecules, or genes, gene products, enzymes, or hormones. Complex organ functions or general characteristic changes in biological structures can likewise serve as biomarkers. Although the term biomarker is relatively new, biomarkers have been used for a long time in pre-clinical research and clinical diagnosis.
For example, body temperature is a well-known biomarker for fever and blood pressure is used to determine the risk of stroke.
In the classical sense biomarker analysis comprises plasma, serum or tissue biomarker analysis on protein level, but more and more biomarker analysis on genetic/genomic level gain in importance. Eurofins Medigenomix focuses on analysis on the latter mentioned level and thus complements very well the services in the area of biomarker analysis of the other Eurofins companies, like Eurofins Global Central Laboratory.
In the field of biomarker analysis Eurofins Medigenomix offers a broad spectrum of services including genotyping, SNP and mutation analysis in genes which are relevant for pharmacogenetics / pharmacogenomics and for clinical diagnostics, as well as complete analysis of respective target genes or re-sequencing of individual areas of defined genes. Besides, the service portfolio includes expression analysis of single or groups of target genes and expression profiling on genome level with the goal to identify molecular signatures.
For further information, please contact us: email@example.com